NCT07224321 INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes Status RECRUITING Phase PHASE2
NCT06280703 A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM) Status RECRUITING Phase PHASE1
NCT06236672 Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease Status COMPLETED Phase N/A
NCT05904743 INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes Status COMPLETED Phase PHASE4
NCT05161429 BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes Status UNKNOWN Phase N/A
NCT04864977 A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes Status WITHDRAWN Phase PHASE4
NCT04809311 Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments Status COMPLETED Phase N/A
NCT02974244 Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins Status COMPLETED Phase N/A
NCT02941367 Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan Status COMPLETED Phase PHASE4
NCT02917057 Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment Status COMPLETED Phase N/A
NCT02846233 Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? Status COMPLETED Phase NA
NCT02803918 A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE1
NCT02033889 A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007). Status COMPLETED Phase PHASE3
NCT01871558 Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin Status COMPLETED Phase PHASE3
NCT01850615 Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01060059 Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes Status COMPLETED Phase N/A
NCT00866658 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA) Status COMPLETED Phase PHASE3
NCT00715624 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin Status COMPLETED Phase PHASE3